Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
Nat Metab. 2019 Aug;1(8):754-764. doi: 10.1038/s42255-019-0095-y. Epub 2019 Aug 12.
The discovery of leptin changed the view of adipose tissue from that of a passive vessel that stores fat to that of a dynamic endocrine organ that actively regulates behaviour and metabolism. Secreted by adipose tissue, leptin functions as an afferent signal in a negative feedback loop, acting primarily on neurons in the hypothalamus and regulating feeding and many other functions. The leptin endocrine system serves a critical evolutionary function by maintaining the relative constancy of adipose tissue mass, thereby protecting individuals from the risks associated with being too thin (starvation and infertility) or too obese (predation). In this Review, the biology of leptin is summarized, and a conceptual framework is established for studying the pathogenesis of obesity, which, analogously to diabetes, can result from either leptin hyposecretion or leptin resistance. Herein, these two states are distinguished with the terms 'type 1 obesity' and 'type 2 obesity': type 1 obesity describes a subset of obese individuals with low endogenous plasma leptin levels who respond to leptin therapy, whereas type 2 obesity describes most obese individuals, who are leptin resistant but might respond to leptin therapy in combination with other drugs, such as leptin sensitizers.
瘦素的发现改变了人们对脂肪组织的看法,从一个储存脂肪的被动容器转变为一个积极调节行为和新陈代谢的动态内分泌器官。脂肪组织分泌的瘦素作为负反馈循环中的传入信号,主要作用于下丘脑神经元,并调节摄食和许多其他功能。瘦素内分泌系统通过维持脂肪组织质量的相对恒定,发挥着至关重要的进化功能,从而保护个体免受过瘦(饥饿和不育)或过胖(被捕食)的风险。在这篇综述中,总结了瘦素的生物学特性,并建立了一个研究肥胖发病机制的概念框架,类似于糖尿病,肥胖既可以由瘦素分泌不足引起,也可以由瘦素抵抗引起。在此,将这两种状态分别命名为“1 型肥胖”和“2 型肥胖”:1 型肥胖描述了一组肥胖个体,他们内源性血浆瘦素水平较低,对瘦素治疗有反应,而 2 型肥胖描述了大多数肥胖个体,他们对瘦素有抵抗性,但可能对瘦素治疗联合其他药物(如瘦素增敏剂)有反应。